Meta Platforms (NASDAQ: META) beats Q2-2026 adjusted EPS consensus of approx. $6.20 per share (July 30, 2026)
Miss
✦ AI-generated prediction
Published on 14. July 2026
·
Predicted for 30. July 2026
·
Based on: Historical Cycle
Meta has beaten adjusted EPS consensus in 7 consecutive quarters, most recently Q1 2026 with EPS ~$6.43 (consensus ~$5.92, +8.6%). Q2 drivers: Advantage+ AI ad optimization increases CPM despite moderated ad budget growth; WhatsApp Business API and Click-to-Messaging Ads increasingly monetized; Llama 4 infrastructure lowers compute cost per token; Reels monetization continues double-digit YoY growth. US CPI at 3.8% YoY and higher commodity prices (Iran crisis) increase FMCG brand ad spend, supporting Meta revenues. Meta expected to report on July 30, 2026 after market close. Wall Street EPS consensus Q2 2026: approximately $6.20.
Data basis for this prediction
- Meta Q1 2026: EPS $6,43 vs. Konsens $5,92 (+8,6 %) – 7. Konsensschlag in Folge (Meta IR, Mai 2026)
- Meta Advantage+ AI-Werbeerträge: zweistelliges YoY-Wachstum (Meta Q1 2026 Earnings Call)
- Wall Street EPS-Konsens META Q2 2026: ca. 6,20 USD (aggregierter Konsens, Stand 14.07.2026)
- Meta Q2 2026 Ergebnis-Datum: ca. 30. Juli 2026 nach US-Börsenschluss (Meta IR Calendar)
Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.
Verdict: Miss
Meta berichtete am 29./30. Juli 2026 ein bereinigtes EPS von 6,18 USD und verfehlte damit den tatsächlichen Wall-Street-Konsens von ca. 7,14–7,22 USD je Aktie um rund 14 %. Die Vorhersage ging von einem Konsens von ~6,20 USD aus – dieser war deutlich zu niedrig angesetzt, da Analysten ihre Schätzungen in den Monaten vor dem Bericht stark nach oben revidiert hatten. Die Hauptgründe für das EPS-Miss waren einmalige Belastungen: 2,4 Mrd. USD für Rechtsrückstellungen (Datenschutzverfahren) und 1,2 Mrd. USD an Abfindungskosten, die zusammen mit einem Kostenanstieg von 55 % YoY die Marge von 43 % auf 31 % drückten. Auf der Umsatzseite schlug Meta mit 60,8 Mrd. USD (Konsens: ~60,2 Mrd. USD, +28 % YoY) die Erwartungen. Die Vorhersage des EPS-Beats trat also nicht ein – sowohl wegen der falschen Konsensbasis als auch wegen des operativen Misses. Quellen: https://www.tradingkey.com/analysis/stocks/us-stocks/262063667-meta-stock-crashing-after-q2-2026-earnings-eps-miss-capex-tradingkey | https://finance.yahoo.com/news/meta-misses-on-q2-earnings-stock-tumbles-121325403.html | https://www.sec.gov/Archives/edgar/data/1326801/000162828026050596/meta-06302026xexhibit991.htm
💻 Technology
✦ AI
Applied Materials has beaten the EPS consensus in all four of its last reported quarters, with an average earnings surprise of +3.5%. The company's own Q4 guidance is $3.82–$4.22 per share; consensus at $4.06 sits near the midpoint, reflecting classic conservative management framing. Revenue is estimated at $10.30B (+51% YoY) — TSMC and Samsung have not pulled back H2 2026 capex plans. No Polymarket market directly available; a 100% beat streak over 4 quarters with a positive guidance range implies 70–75% probability. Risk: supply chain delays or expanded US export controls on advanced chips could force a Q5 inventory build.
💻 Technology
✦ AI
PLTR closed at $175.40 on November 4, 2026 (after-hours: $170.88, -2.58%; intraday high: $176.54; 52-week high: $212.94). Palantir clearly beat Q3-FY2026 EPS consensus: total revenue $2.313B, US Commercial revenue +148% YoY to $984M. The $185 threshold is +5.5% above the closing price or +8.3% above after-hours levels. Typical post-earnings 'sell the news' may weigh short-term, but the 52-week high of $212.94 confirms the level is reachable. NVIDIA earnings on November 18, 2026 could serve as a sector-wide catalyst. No direct Polymarket equivalent; own estimate: ~42%.
💻 Technology
✦ AI
CBRS trades at $109.18 (October 30, 2026) — already 61% below its all-time high of $279.72. The final and largest lockup expiration is scheduled for November 10, 2026: approximately 19.4 million shares are unlocked (of three tranches of 19.4M each). Prior lockup tranches have consistently weighed on the stock. Insiders have sold ~$394.6M in shares since the May 2026 IPO — zero insider purchases. A Culper Research short-seller report has triggered multiple investigations. A close below $100 requires a ~8.4% decline — plausible given the expected supply pressure on expiration day.